Chromium: A case study in how not to perform nutritional research

Current Topics in Nutraceutical Research

Volumn 4, Issue 2, 2006, Pages 89-112

  Stallings, Dontarie ^a   Vincent, John B ^b  

^a GEORGIA SOUTHERN UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA   (United States)

Author keywords

Chromate; Chromium; Chromium nicotinate; Chromium picolinate; Cr3; Low molecular weight chromium binding substance

Indexed keywords

BIOTIN; CARBOHYDRATE; CHROMEMATE; CHROMIC ACID; CHROMIUM; CHROMIUM DERIVATIVE; CHROMIUM HISTIDINE; CHROMIUM NICOTINATE; CHROMIUM PICOLINATE; DIACHROME; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR; LIPID; NUTRACEUTICAL; PHOSPHATASE; PLACEBO; PROTEIN KINASE B; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VANADIC ACID;

CARBOHYDRATE METABOLISM; CASE STUDY; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DIET SUPPLEMENTATION; DIETARY INTAKE; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG EXCRETION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; ENZYME ACTIVITY; ENZYME INHIBITION; EVIDENCE BASED PRACTICE; EXTRACELLULAR MATRIX; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GLUCOSE UTILIZATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID METABOLISM; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL DEFICIENCY; NUTRITIONAL REQUIREMENT; NUTRITIONAL SCIENCE; NUTRITIONAL VALUE; PATENT; REVIEW; STATISTICAL SIGNIFICANCE; TOXIC HEPATITIS; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALIA;

EID: 33749071019     PISSN: 15407535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (156)

1. Aghdassi, E., Salit, I. E., Fung, L., Sreetharan, L., Walmsley, S. and Allard, J. P. (2006) Is chromium an important element in HIV-positive patients with metabolic abnormalities? An hypothesis generating pilot study. Journal of the American College of Nutrition 25, 56-63.
2. Althius, M. D., Jordan, N. E., Ludington, E. A. and Wittes, J. T. (2002) Glucose and insulin responses to dietary chromium supplements: A meta-analysis. American Journal of Clinical Nutrition 76, 148-155.
3. Anderson, R. A. (1987) Chromium in Trace Elements in Human and Animal Nutrition, (Mertz, W., Ed.) Vol. 1, pp. 225-244, Academic Press, Orlando.
4. Anderson, R. A. (1998) Chromium, glucose intolerance and diabetes. Journal of the American College of Nutrition 17, 548-555.
5. Anderson, R. A. (1989) Essentiality of chromium in humans. Science of the Total Environment 86, 75-81.
6. Anderson, R. A. (1995) Chromium and parenteral nutrition. Nutrition 11, 83-86.
7. Anderson, R. A., Bryden, N. A. and Polansky, M. M. (1992) Dietary chromium intake. Freely chosen diets, institutional iets, and individual foods. Biological Trace Element Research 32, 117-121.
8. Anderson, R. A., Bryden, N. A. and Polansky, M. M. (1997) Lack of toxicity of chromium chloride and chromium picolinate in rats. Journal of the American College of Nutrition 16, 273-279.
9. Anderson, R. A., Bryden, N. A., Polansky, M. M. and Gautschi, K. (1996) Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats. Journal of Trace Elements in Experimental Medicine 9, 11-25.
10. Anderson, R. A., Bryden, N. A., Polansky, M. M. and Reiser, S. (1990) Urinary chromium excretion and insulinogenic properties of carbohydrates. American Journal of Clinical Nutrition 51, 864-868.
11. Anderson, R. A. and Kozlovsky, A. S. (1985) Chromium intake, absorption and excretion of subjects consuming self-selected diets. American Journal of Clinical Nutrition 41, 1177-1183.
12. Anderson, R. A. and Mertz, W. (1977) Glucose tolerance factor: an essential dietary agent. Trends in Biochemical Sciences 2, 277-279.
13. Anderson, R. A. and Polansky, M. M. (1995) Dietary and metabolite effects on trivalent chromium retention and distribution in rats. Biological Trace Element Research 50, 97-108.
14. Anderson, R. A., Polansky, M. M. and Bryden, N. A. (2004) Stability and absorption of complexes of chromium and absorption of chromium histidine complexes by humans. Biologicak Trace Element Research 101, 211-218.
15. Anderson, R. A., Polansky, M. M., Bryden, N. A., Bhathena, S. J. and Canary, J. J. (1987) Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism 36, 351-355.
16. Anderson, R. A., Polansky, M. M., Bryden, N., Roginski, E. E., Patterson, K. Y. and Reamer, D. C. (1982a) Effect of exercise (running) on serum glucose, insulin, glucagon, and chromium excretion. Diabetes 31, 212-216.
17. Anderson, R. A., Polansky, M. M., Bryden, N. A., Roginski, E. E., Patterson, K. Y., Veillon, C. and Glinsmann, W. (1982b) Urinary chromium excretion of human subjects: Effects of chromium supplementation and glucose loading. American Journal of Clinical Nutrition 36, 1184-1193.
18. Bagchi, D., Bagchi, M., Balmoori, J., Ye, Y. and Stohs, S. J. (1997) Comparative induction of oxidative stress in cultured J774A.1 macrophage cells by chromium picolinate and chromium nicotinate. Research. Communications in Molecular Pathology and Pharmacology 97, 335-346.
19. Bagchi, D., Stohs, S. J., Downs, B. W., Bagchi, M. and Preuss, H. G. (2002) Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180, 5-22.
20. Bailey, M. M., Boohaker, J. G., Sawyer, R. D., Behling, J. E., Rasco, J. F., Jemigan, J. J., Hood, R. D. and Vincent, J. B. (2006) Exposure of pregnant mice to chromium picolinate results in skeletal defects in their offspring. Birth Defect Research, in press.
21. Berkeley Wellness Letter. Wellness Guide to Dietary Supplements: Chromium. http://www.berkeley.com/html/ds/dsChromium.php (accessed April 10, 2006).
22. Broadhurst, C. L., Schmidt, W. F., III, J. B. R., Polansky, M. M., Gautschi, K. and Anderson, R. A. (1997) Characterization and structure by NMR and FTIR spectroscopy, and molecular modeling of chromium(III) picolinate and nicotinate complexes utilized for nutritional supplementation. Journal of Inorganic Biochemistry 66, 119-130.
23. Borel, J. S., Majerus, T. C., Polansky, M. M., Moser, P. B. and Anderson, R. A. (1984) Chromium intake and urinary chromium excretion of trauma patients. Biological Trace Element Research 6, 317-326.
24. 2]. Inorganic Chemistry 24, 3724-3725.
25. Brown, R. O., Forloines-Lynn, S., Cross, R. E. and Heizer, W. D. (1986) Chromium deficiency after long-term total parenteral nutrition. Digest of Disease Science 31, 661-664.
26. Bunker, V. W., Lawson, M. S., Delves, H. T. and Clayton, B. E. (1984) The uptake and excretion of chromium by the elderly. American Journal of Clinical Nutrition 39, 797-802.
27. Catelas, I., Petit, A., Zukor, D. J., Antoniou, J. and Huk, O. L. (2002) TNF-? secretion and macrophage mortality induced by cobalt and chromium ion in in vitro - Qualitative analysis of apoptosis. Biomaterials 24, 383-391.
28. Cefalu, W. T., Martin, J. M., Wachtel, D., Zhang, X. H. and Wang, Z. Q. (2003) Chromium picolinate supplementation increases insulin-stimulated Akt phosphorylation in vivo in skeletal muscle from subjects with type 2 diabetes. 18th International Diabetes Federation Congress, August 24-29, 2003, PARIS - France, Abstract 154.
29. Cefalu, W. T., Wang, Z. Q., Zhang, X. H., Baldor, L. C. and Russell, J. C. (2002) Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA) rats. Journal of Nutrition 132, 1107-1114.
30. Chaudhary, S., Pinkston, J., Rabile, M. M. and Van Horn, J. D. (2005) Unusual reactivity in a commercial chromium supplement compared to baseline DNA cleavage with synthetic chromium complexes. Journal of Inorganic Biochemistry 99, 787-794.
31. Chen, G., Liu, P., Pattar, G. R., Tackett, L., Bhonagiri, P., Strawbridge, A. B. and Elmendorf, J. S. (2006) Chromium activates GLUT4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Molecular Endocrinology, in press.
32. Chromium454, http://www.futureceuticals.com/proprietary/pdf/ chromium454Brochure.pdf (accessed March 6, 2006).
33. 3-oxo-μ3-hexapropionatotrichromium(III) in rats. Biological Trace Element Research 98, 522-533.
34. 3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. Journal of Biological Inorganic Chemistry 10, 119-130.
35. Clodfelder, B. J. and Vincent, J. B. (2005) The time-dependent transport of chromium in adult rats from the bloodstream to the urine. Journal of Biological Inorganic Chemistry 10, 383-393.
36. Davies, D. M., Holdsworth, E. S. and Sherriff, J. L. (1985) The isolation of glucose tolerance factors from brewer's yeast and their relationship to chromium. Biochemical Medicine 33, 297-311.
37. Davis, S., McLaren, H. J., Hunnisett, A. and Howard, M. (1997a) Age-related decrease in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients: Implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism 46, 469-473.
38. Davis, C. M., Royer, A. C. and Vincent, J. B. (1997b) Synthetic multinuclear chromium assembly activates insulin receptor tyrosine kinase activity: Functional model for low-molecular-weight chromium-binding substance. Inorganic Chemistry 36, 5316-5320.
39. Davis, C. M., Sumrall, K. H. and Vincent, J. B. (1996) The biologically active form of chromium may activate a membrane phosphotyrosine phopshatase (PTP). Biochemistry 35, 12963-12969.
40. Davis, C. M. and Vincent, J. B. (1997a) Isolation and characterization of a biologically active form of chromium oligopeptide from bovine liver. Archives of Biochemistry and Biophysics 339, 335-343.
41. Davis, C. M. and Vincent, J. B. (1997b) Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 36, 4382-4385.
42. Debski, B., Krejpcio, Z., Kuryl, T., Wojciak, R. and Lipko, M. (2004) Biomimetic chromium(III) complex and fructan supplementation affect insulin and membrane glucose transport in rats. Journal of Trace Elements in Experimental Medicine 17, 206-207.
43. Dinakarpandian, D., Morrissette, V., Chaudhary, S., Amini, K., Bennett, B. and Van Horn, J. D. (2004) An informatics search for the low-molecular weight chromium-binding peptide. BMC Chemical Biology 4:2 (www.biomedcentral.com/1472-6769/4/2).
44. Dowling, H. J., Offenbacher, E. G. and Pi-Sunyer, F. X. (1990) Effects of plasma transferrin and albumin on the absorption of trivalent chromium. Nutrition Research 10, 1251-1260.
45. Esber, H., Moreno, V. and Loveday, K. (1997) Evaluation of chromium picolinate in the Ames and the rat in vivo chromosomal aberration assays [abstract]. Mutation Research 379 (1 Suppl.), S89.
46. Evans, G. W. (1989a) The effect of chromium picolinate on insulin controlled parameters in humans. International Journal of Biosocial and Medicinal Research 11, 163-180.
47. Evans, G. W. and Bowman, T. D. (1992) Chromium picolinate increases membrane fluidity and rate of insulin internalization. Journal of Inorganic Biochemistry 46, 243-250.
48. Evans, G. W. and Meyer, L. (1992) Chromium picolinate increases longevity. Age 15, 134.
49. Evans, G. W. and Pouchnik, D. J. (1993) Composition and biological activity of chromium-pyridine carboxylate complexes. Journal of Inorganic Biochemistry 49, 177-187.
50. Federal Trade Commission (1997) Docket No. C-3758 Decision and Order (http://www.ftc.gov/os/1997/07/nutritid.pdf, accessed Feb. 2, 2006).
51. Fernandez-Lopez, J.-A., Esteve, M., Rafecas, I., Remesar, X. and Alemany, M. (1994) Management of dietary essential metals (iron, copper, zinc, chromium, and manganese) by Wistar and Zucker obese rats fed a self-selected high-energy diet. BioMetals 7, 117-129.
52. Freund, H., Atamian, S. and Fischer, J. E. (1979) Chromium deficiency during total parenteral nutrition. JAMA 241, 496-498.
53. Gaggelli, E.; Berti, F., D'Amelio, N., Gaggelli, N., Valensin, G., Bovalini, L., Paffetti, A. and Trabalzini, L. (2002) Metabolic pathways of carcinogenic chromium. Environmental Health Perspectives 110(Suppl. 5), 733-738.
54. Gibson, R. S. and Scythes, C. A. (1984) Chromium, selenium, and other trace element intakes of a selected sample of Canadian premenopausal women. Biological Trace Element Research 6, 105-116.
55. Goldstein, B. J., Zhu, L., Hager, R., Zilbering, A., Sun, Y. and Vincent, J. B. (2001) Enhancement of post-receptor insulin signaling by trivalent chromium in hepatoma cells is associated with differential inhibition of specific protein-tyrosine phosphatases. Journal of Trace Elements in Experimental Medicine 14, 393-404.
56. Goto, Y. and Kida, K. (1995) Insulin-like action of chromate on glucose transport in isolated rat adipocytes. Japanese Journal of Pharmacology 67, 365-368.
57. Green, C. A., Bianchini, R. J. and Legg, J. I. (1984) Characterization of a stable chromium(III)-nicotinic acid complex by deuteron NMR. Inorganic Chemistry 23, 2713-2715.
58. 2O. Inorganica Chimica Acta 176, 87-93.
59. Gudi, R., Slesinski, R. S., Clarke, J. J. and Sans, R. H. C. (2005) Chromium picolinate does not produce chromosome damage in CHO cells. Mutation Research 587, 140-146.
60. Gullar, E., Jimenez, F. J., van't Veer, P., Bode, P., Riemersma, R. A., Gomez-Aracena, J., Kark, J. D., Arab, L., Kok, F. J. and Martin-Moreno, J. M. (2005) EURAMIC-Heavy Metals and Myocardial Infarction Study Group. Low toenail chromium concentration and increased risk of nonfatal myocardial infarction. American Journal of Epidemiology 162, 157-164.
61. Held, D. D., Gonzalez-Vergara, E. and Goff, H. M. (1984) Isolation of a non-chromium insulin-enhancing factor from brewer's yeast. Federation Proceedings 43, 472.
62. Hellerstein, M. K. (1998) Is chromium supplementation effective in managing type II diabetes? Nutrition Reviews 56, 302-306.
63. Hepburn, D. D. D., Burney, J., Woski, S. A. and Vincent, J. B. (2003a) The nutritional supplement chromium picolinate generates oxidative DNA damage and peroxidized lipids in vivo. Polyhedron 22, 455-463.
64. Hepburn, D. D. D., Xiao, J., Bindom, S., Vincent, J. B. and O'Donnell, J. (2003b) Nutritional supplement chromium picolinate causes sterility and lethal mutations in Drosophila melanogaster, Processions of the National Academy of Science, USA 100, 3766-3771.
65. Holdsworth, E. S., Kaufman, D. V., and Neville, E. (1991) A fraction derived from brewer's yeast inhibits cholesterol synthesis by rat liver preparations in vitro. British Journal of Nutrition 65, 285-299.
66. Holdsworth, E. S. and Neville, E. (1988) Extracts of brewer's yeast contain GABA which enhances activation of glycogen synthetase by insulin in isolated rat hepatocytes. Biochemistry International 17, 1107-1116.
67. Holdsworth, E. S. and Neville, E. (1990) Effects of extracts of high- and low-chromium brewer's yeast on metabolism of glucose by hepatocytes from rats fed on high- or low-Cr diets. British Journal of Nutrition 63, 623-630.
68. Hwang, D. L., Lev-Ran, A., Papoian, T. and Beech, W. K. (1987) Insulin-like activity of chromium-binding fractions from brewer's yeast. Journal of Inorganic Biochemistry 30, 219-225.
69. Jacquamet, L., Sun, Y., Hatfield, J., Gu, W., Cramer, S. P., Crowder, M. W., Lorigan, G. A., Vincent, J. B. and Latour, J.-M. (2003) Characterization of chromodulin by X-ray absorption and electron paramagnetic spectroscopy and magnetic susceptibility measurements. Journal of the American Chemical Society 125, 774-780.
70. Jain, S. K. and Kannan, K. (2001) Chromium chloride inhibits oxidative stress and TNF-? secretion caused by exposure to high glucose in cultured U937 monocytes. Biochemical and Biophysical Research Communications 289, 687-691.
71. Jain, S. K., Rogier, K., Prouty, L. and Jain, S. K. (2004) Protective effects of 17?-estradiol and trivalent chromium on interleukin-6 secretion, oxidative stress, and adhesion of monocytes: Relevance to heart disease in postmenopausal women. Free Radicals in Biology and Medicine 37, 1730-1735.
72. Jeejeebhoy, K. N. (1999a) The role of chromium in nutrition and therapeutics and as a potential toxin. Nutrition Reviews 57, 329-335.
73. Jeejeebhoy, K. N. (1999b) Chromium and parenteral nutrition. Journal of Trace Elements in Experimental Medicine 12, 85-89.
74. Jeejeebhoy, K. N., Chu, R. C., Marliss, E. B., Greenberg, G. R. and Bruce-Robertson, A. (1977) Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long term total parenteral nutrition. American Journal of Clinical Nutrition 30, 531-538.
75. Kato, I., Vogelman, J., Dilman, V., Karkoszka, J., Frenkel, K., Durr, N. P., Orentreich, N. and Toniolo, P. (1998) Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil. European Journal of Epidemiology 14, 621-626.
76. Kim, E. and Na, K. J. (1991) Effect of sodium dichromate on carbohydrate metabolism. Toxicology and Applied Pharmacology 110, 251-258.
77. Kim, G. and Yurkow, E. J. (1996) Chromium induces a persistent activation of mitogen-activated protein kinases by a redox-sensitive mechanism in H4 rat hepatoma cells. Cancer Research 56, 2045-2051.
78. Kingry, K. F., Rowyer, A. C. and Vincent, J. B. (1998) Nuclear magnetic resonance studies of chromium(III) pyridinecarboxylate complexes. Journal of Inorganic Biochemistry 72, 79-88.
79. Kleefstra, N., Houweling, S. T., Jansman, F. G. A., Gronier, K. H., Gans, R. O. B., Meyboom-de Jong, B., Bakker, S. J. L. and Bilko, H. J. G. (2006) Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: A randomized, double-blind, placebo-controlled trial. Diabetes Care 29, 521-525.
80. Komorowski, J. and Loveday, K. (1999) Rat chromosomes are unharmed by orally administered chromium picolinate [abstract]. Journal of the American College of Nutrition 18, 527.
81. Kordella, T. (2004) Chromium: Can it help kids with type 2? Diabetes Forecast 57, 83-85.
82. Kozlovsky, A. S., Moser, P. B., Reiser, S. and Anderson, R. A. (1986) Effects of diets high in simple sugars on urinary chromium losses. Metabolism 35, 515-518.
83. Lanca, S., Alves, A., Veira A. I., Barata, J., de Freitas, J. and de Carvalho, A. (2002) Chromium-induced toxic hepatitis. European Journal of Internal Medicine 13, 518-520.
84. Lefavi, R. G. (1993) Response. International Journal Sport Nutrition 3, 120-122.
85. Lefavi, R. G., Anderson, R. A., Keith, R. E., Wilson, G. D., McMillan, J. L. and Stone, M. H. (1992) Efficacy of chromium supplementation in athletes: Emphasis on anabolism. International Journal of Sport Nutrition 2, 111-122.
86. Levina, A., Codd, R., Dillion, C. T. and Lay, P. A. (2003) Chromium in biology: Toxicology and nutritional aspects. Progress in Inorganic Chemistry 51, 145-644.
87. Levina, A. and Lay, P. A. (2005) Mechanistic studies of relevance to the biological activities of chromium. Coordination Chemistry Reviews 249, 281-298.
88. Luo, L., Petit, A., Antoniou, J., Zukor, D. J., Huk, O. L., Liu, R. C. W., Winnik, F. M. and Mwale, F. (2005) Effect of cobalt and chromium ions on MMP-1, TIMP-1, and TNF- α-gene expression in human U937 macrophages: A role for tyrosine kinases. Biomaterials 26, 5587-5593.
89. Machalinski, B., Walczak, M., Syrenicz, A., Machlinska, A., Grymula, K., Stecewicz, I., Wisnieswska, B. and Dabkowska, E. (2006) Hypoglycemic potency of novel trivalent chromium in hyperglycemic insulin-deficient rats. J. Trace Elem. Med. Biol., in press.
90. Manygoats, K. R., Yazzie, M. and Stearns, D. M. (2002) Ultrastructural damage in chromium-picolinate-treated cells: A TEM study. Journal of Biological Inorganic Chemistry 7, 791-798.
91. Meador, W. E., Means, R. A. and Quiocho, F. A. (1992) Target enzyme recognition: 2.4 Å structure of a calmodulin-peptide complex. Science 257, 1251-1255.
92. Mertz, W. and Schwarz, K. (1955) Impaired intravenous glucose tolerance as an early sign of dietary necrotic liver degeneration. Archives of Biochemistry and Biophysics 58, 504-506.
93. Mertz, W., Toepfer, E. W., Roginski, E. E. and Polansky, M. M. (1974) Present knowledge of the role of chromium. Federation Proceedings 33, 2275-2280.
94. Morris, B. W., Blumsohn, A., Mac Neil, S. and Gray, T. A. (1992) The trace element chromium - A role in glucose homeostasis. American Journal of Clinical Nutrition 55, 989-991.
95. Morris, B. W., Griffiths, H. and Kemp, G. J. (1988a) Effect of glucose loading on concentrations of chromium in plasma and urine of healthy adults. Clinical Chemistry 34, 1114-1116.
96. Morris, B. W., Griffiths, H. and Kemp, G. J. (1988b) Correlations between abnormalities in chromium and glucose metabolism in a group of diabetics. Clinical Chemistry 34, 1525-1526.
97. Morris, B., MacNeil, S., Fraser, R. and Gray, T. (1995) Increased urine chromium excretion in normal pregnancy. Clinical Chemistry 41, 1544-1545.
98. Morris, B. W., MacNeil, S., Hardisty, C. A., Heller, S., Burgin, C. and Gray, T. A. (1999) Chromium homeostasis in patients with type II (NIDDM) diabetes. Journal of Trace Elements in Medicine and Biology 13, 57-61.
99. Morris, B. W., MacNeil, S., Stanley, K., Gray, T. A. and Fraser, R (1993) The inter-relationship between insulin and chromium in hyperinsulinaemic euglycaemic clamps in healthy volunteers. Journal of Endocrinology 139, 339-345.
100. Mulkani, I., Levina, A. and Lay, P. A. (2004) Biomimetic oxidation of chromium(III): Does the antidiabetic activity of chromium(III) involve carcinogenic chromium(VI)? Angewandte Chemie International Edition 43, 4504-4507.
101. National Research Council (1980) Recommended Dietary Allowances, 9th Ed. Report of the Committee on Dietary Allowances, Division of Biological Sciences, Assembly of Life Science, Food and Nutrition Board, Commission on Life Science, National Research Council. National Academy Press, Washington, D. C.
102. National Research Council (1989) Recommended Dietary Allowances, 10th Ed. Subcommittee on the Tenth Edition of the RDAs,, Food and Nutrition Board, Commission on Life Science, National Research Council. National Academy Press, Washington, D. C.
103. National Research Council (2002) Dietary Reference Intakes for vitamin A, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. A report of the Panel on Micronutrients, Subcommittee on Upper Reference Levels of Nutrients and of Interpretations and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. National Academy of Sciences, Washington, D. C.
104. Nielsen, F. H. (1996) Controversial chromium: Does the superstar mineral of the Montebanks receive appropriate attention from clinicians and nutritionists? Nutrition Today 31, 226-233.
105. Nielsen, F. H. (2007) Summary: The clinical and nutritional importance of chromium - Still debated after 50 years of research. In: Vincent, J. B., (Ed.) The Nutritional Biochemistry of Chromium(III), (Amsterdam: Elsevier) in press.
106. Nissen, S. L. and Sharp, R. L. (2003) Effect of dietary supplements on lean mass and strength gains with resistance exercise: A meta-analysis. Journal of Applied Physiology 94, 651-659.
107. Offenbacher, E. G., Spencer, H., Dowling, H. J. and Pi-Sunyer, F. X. (1986) Metabolic chromium balances in men. American Journal of Clinical Nutrition 44, 77-82.
108. 51Cr picolinate in a rat model. Trace Elements and Electrolytes 11, 182-186.
109. 3-oxo-μ-hexapropionatotrichromium(III) inhibits colorectal tumor formation in rats. Journal of Inorganic Biochemistry 98, 1303-1306.
110. Pittler, M. H., Stevinson, C. and Ernst, E. (2003) chromium picolinate for reducing body weight: meta-analysis of random trials. International Journal of Obesity 27, 522-529.
111. Press, R. I., Geller, J. and Evans, G. W. (1990) The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. Western Journal of Medicine 152, 41-45.
112. Preuss, H. G., Echard, B., Polansky M. M. and Anderson, R. A. (2006) Whole cinnamon and aqueous extracts ameliorate sucrose-induced blood pressure elevations in spontaneously hypertensive rats. Journal of the American College of Nutrition 25, 144-150.
113. Preuss, H., Grojec, P., Lieberman, S. and Anderson, R. A. (1997) Effects of different chromium compounds on blood pressure and peroxidation in spontaneously hypertensive rats. Clinical Nephrology 47, 325-330.
114. Rajpathak, S., Rimm, E. B., Li, T., Morris, J. S., Stampfer, M. J., Willet, W. C. and Hu, F. B. (2004) Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 27, 2211-2216.
115. 1 mice following subchromic administration of chromium picolinate monohydrate. Food Chemical Toxicology 43, 21-29.
116. Rindgen, D., Lee, S., Nakajima, M. and Blair, I. A. (2000) Formation of a substituted 1,N-etheno-2′-deoxyadenosine adduct by lipid hydroperoxide-mediated generation of 4-oxo-2-nonenal. Chemical Research and Toxicology 13, 846-852.
117. Schwarz, K. and Mertz, W. (1957) A glucose tolerance factor and its differentiation from factor 3. Archives of Biochemistry and Biophysics 72, 515-518.
118. Schwarz, K. and Mertz, W. (1959) Chromium(III) and the glucose tolerance factor. Archives of Biochemistry and Biophysics 85, 292-295.
119. Shara, M., Yasmin, T., Kincaid, A. E., Limpach, A. L., Bartz, J., Brenneman, K. A., Chatterjee, A., Bagchi, M., Stohs, S. J. and Bagchi, D. (2005) Safety and toxicological evaluation of a novel niacin-bound chromium(III) complex. Journal of Inorganic Biochemistry 99, 2161-2183.
120. Shute, A. A. and Vincent, J. B. (2001) The stability of the biomimetic cation triaqua-μ-oxohexapropionatotrichromium(III) in vivo in rats. Polyhedron 20, 2241-2252.
121. Simonoff, M., Shapcott, D., Alameddine, S., Sutter-Dub, M. T. and Simonoff, G. (1992) The isolation of glucose tolerance factors from Brewer's yeast and their relation to chromium. Biological Trace Element Research 32, 25-38.
122. Scully, R. E., Mark, E. J., McNeely, W. F. and McNeely, B. U. (1990) Case records of the Massachusetts General Hospital: Case 12-1990. New England Journal of Medicine 322, 829-841.
123. Slesinski, R. S., Clarke, J. J., San, R. H. C. and Gudi, R. (2005) Lack of mutagenicity of chromium picolinate in the hypoxanthine phosphoribosyltransferase gene assay in Chinese hamster ovary cells. Mutation Research 585, 86-95.
124. Speetjens, J., Collins, R., Vincent, J. B. and Woski, S. A. (1999a) The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chemical Research and Toxicology 12, 483-487.
125. + do not cleave DNA under physiologically-relevant conditions. Polyhedron 18, 2617-2624.
126. Stearns, D. M. (2000) Is chromium a trace essential element? Biofactors 11, 149-162.
127. Stearns, D. M., Silveira, S. M., Wolf, K. K. and Luke, A. M. (2002) Chromium(III) tris(picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells. Mutation Research 513, 135-142.
128. Stearns, D. M., Wise Sr., J. P., Patierno, S. R. and Wetterhahn, K. E. (1995) Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB Journal 9, 1643-1648.
129. Striffler, J. S., Law, J. S., Polansky, M. M., Bhathena, S. J. and Anderson, R. A. (1995) Chromium improves insulin response to glucose in rats. Metabolism 44, 1314-1320.
130. Strifller, J. S., Polansky, M. M. and Anderson, R. A. (1998) Dietary chromium decreases insulin resistance in rats fed a high fat mineral imbalanced diet. Metabolism 47, 396-400.
131. Strifller, J. S., Polansky, M. M. and Anderson, R. A. (1999) Overproduction of insulin in the chromium-deficient rat. Metabolism 48, 1063-1068.
132. Sugden, K., Geer, R. and Rogers, S. (1992) Oxygen radical-mediated DNA damage by redox-active Cr(III) complexes. Biochemistry 31, 11626-11631.
133. + decreases plasma insulin, cholesterol and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. Journal of Biological Inorganic Chemistry7, 852-862.
134. + decreases plasma cholesterol and triglycerides in rats:towards chromium-containing therapeutics. Journal of Biological Inorganic Chemistry 4, 838-845.
135. 3 to LMWCr. Journal of Biological Inorganic Chemistry 5, 129-136.
136. Toepfer, E. W., Mertz, W., Polansky, M. M., Roginski, E. E. and Wolf., W. R. (1977) Preparation of chromium-containing material of glucose tolerance factor activity from brewer's yeast extracts and by synthesis. Journal of Agricultural and Food Chemistry 25, 162-162.
137. Veillon, C. and Patterson, K. Y. (1999) Analytical issues in nutritional chromium research. Journal of Trace Elements in Experimental Medicine 12, 99-109.
138. Verhage, A. H., Cheong, W. K. and Jeejeebhoy, K. N. (1996) Neurologic symptoms due to possible chromium deficiency in long-term parenteral nutrition that closely mimic metronidazole-induced syndromes. JPEN 20, 123-127.
139. Vincent, J. B. (1994) Relationship between glucose tolerance factor and low-molecular-weight chromium-binding substance. Journal of Nutrition 124, 117-118.
140. Vincent, J. B. (1999) Mechanism of action of chromium: low-molecular-weight chromium-binding substance. Journal of the American College of Nutrition 18, 6-12.
141. Vincent, J. B. (2001) The bioinorganic chemistry of chromium(III). Polyhedron 20, 1-26.
142. Vincent, J. B. (2004a) The potential value and potential toxicity of chromium picolinate as a nutritional supplement, weight loss agent, and muscle development agent. Sports Medicine 33, 213-230.
143. Vincent, J. B. (2004b) Recent developments in the biochemistry of chromium (III). Biological Trace Element Research 99, 1-16.
144. Vincent, J. B. and Hatfield, M. J. (2004) The Nutritional Biochemistry of Chromium: Roles for Transferrin and Chromodulin? Nutrition Abstracts Reviews Series A: Human and Experimental 74, 15N-23N.
145. Vincent, J. B., Hatfield, J. and Burdette, S. (2004) Characterizing chromium-containing oligopeptides. Abstracts of the 227th ACS National Meeting, Anaheim, CA, March 28-April 1, 2004, CHED 381.
146. Wada, O., Wu, G. Y., Yamamoto, A., Manabe, S. and Ono, T. (1983) Purification and chromium-excretory function of low-molecular-weight, chromium-binding substances from dog liver. Environmental Research 32, 228-239.
147. Wang, H., Kruszewski, A. and Brautigan, D. L. (2005) Cellular chromium enhances activation of insulin receptor kinase. Biochemistry 44, 8167-8175.
148. Wang, Z. Q., Zhang, X. H., Russell, J. C., Hulver, M., and Cefalu, W. T. (2006) Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. Journal of Nutrition 136, 415-420.
149. Whitaker, P., San, R. H. C., Clarke, J. J., Seifried, H. E. and Dunkel, V. C. (2005) Mutagenicity of chromium picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells. Food and Chemical Toxicology 43, 1619-1625.
150. Woolliscroft, J. and Barbosa, J. (1977) Analysis of chromium induced carbohydrate intolerance in the rat. Journal of Nutrition 107, 1702-1706.
151. Yamamoto, A., Wada, O. and Manabe, S. (1989) Evidence that chromium is an essential factor for biological activity of low-molecular-weight Cr-binding substance. Biochemical and Biophysical Research Communications 163, 189-193.
152. Yamamoto, A., Wada, O. and Ono, T. (1984) Distribution and chromium-binding capacity of a low-molecular-weight, chromium-binding substance in mice. Journal of Inorganic Biochemistry 22, 91-102.
153. Yamamoto, A., Wada, O. and Suzuki, H. (1988) Purification and properties of biologically active chromium complex from bovine colostrum. Journal of Nutrition 118, 39-45.
154. 3 improves insulin responsiveness and reduces whole body glucose tolerance. FEBS Letters 579, 1458-1464.
155. Yoshimoto, S., Sakamoto, K., Wakabayashi,I. and Masui, H. Effect of chromium on glucose tolerance in stroke-prone spontaneously hypertensive rats with streptozotocin-induced diabetes. (1992) Metabolism 41, 636-642.
156. Yurkow, E. J. and Kim, G. (1995) Effects of chromium on basal and insulin-induced tyrosine phosphorylation in H4 hepatoma cells: comparison with phorbol-12-myristate-13-acetate and sodium orthovanadate. Molecular Pharmacology 47, 686-695.